Sign In
MIME-Version: 1.0 X-Document-Type: Workbook Content-Type: multipart/related; boundary="----=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8" This document is a Single File Web Page, also known as a Web Archive file. If you are seeing this message, your browser or editor doesn't support Web Archive files. Please download a browser that supports Web Archive, such as Microsoft Internet Explorer. ------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Workbook.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"

This page should be opened with Microsoft Excel XP or newer.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet01.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Document and Entity Information
3 Months Ended
Dec. 27, 2014
Jan. 09, 2015
Document Type 10-Q
Amendment Flag false
Document Period End Date Dec 27, 2014
Document Fiscal Year Focus 2015
Document Fiscal Period Focus Q1
Trading Symbol AAPL
Entity Registrant Name APPLE INC
Entity Central Index Key 0000320193
Current Fiscal Year End Date --09-26
Entity Filer Category Large Accelerated Filer
Entity Common Stock, Shares Outstanding 5,824,748,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet02.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Millions, except Share data in Thousands, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Net sales $ 74,599 $ 57,594
Cost of sales 44,858 35,748
Gross margin 29,741 21,846
Operating expenses:
Research and development 1,895 1,330
Selling, general and administrative 3,600 3,053
Total operating expenses 5,495 4,383
Operating income 24,246 17,463
Other income/(expense), net 170 246
Income before provision for income taxes 24,416 17,709
Provision for income taxes 6,392 4,637
Net income $ 18,024 $ 13,072
Earnings per share:
Basic $ 3.08 $ 2.08
Diluted $ 3.06 $ 2.07
Shares used in computing earnings per share:
Basic 5,843,082 6,272,504
Diluted 5,881,803 6,310,161
Cash dividends declared per common share $ 0.47 $ 0.44
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet03.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Net income $ 18,024 $ 13,072
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax (66) (67)
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax 1,982 213
Adjustment for net losses/(gains) realized and included in net income, net of tax (565) 72
Total change in unrecognized gains/losses on derivative instruments, net of tax 1,417 285
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax (456) (42)
Adjustment for net losses/(gains) realized and included in net income, net of tax (14) (11)
Total change in unrealized gains/losses on marketable securities, net of tax (470) (53)
Total other comprehensive income/(loss) 881 165
Total comprehensive income $ 18,905 $ 13,237
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet04.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Current assets:
Cash and cash equivalents $ 19,478 $ 13,844
Short-term marketable securities 12,985 11,233
Accounts receivable, less allowances of $87 and $86, respectively 16,709 17,460
Inventories 2,283 2,111
Deferred tax assets 5,046 4,318
Vendor non-trade receivables 13,267 9,759
Other current assets 13,635 9,806
Total current assets 83,403 68,531
Long-term marketable securities 145,492 130,162
Property, plant and equipment, net 20,392 20,624
Goodwill 4,629 4,616
Acquired intangible assets, net 4,370 4,142
Other assets 3,608 3,764
Total assets 261,894 231,839
Current liabilities:
Accounts payable 38,001 30,196
Accrued expenses 22,724 18,453
Deferred revenue 8,987 8,491
Commercial paper 3,899 6,308
Total current liabilities 73,611 63,448
Deferred revenue - non-current 3,480 3,031
Long-term debt 32,504 28,987
Other non-current liabilities 28,971 24,826
Total liabilities 138,566 120,292
Commitments and contingencies      
Shareholders' equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,826,419 and 5,866,161 shares issued and outstanding, respectively 24,187 23,313
Retained earnings 97,178 87,152
Accumulated other comprehensive income/(loss) 1,963 1,082
Total shareholders' equity 123,328 111,547
Total liabilities and shareholders' equity $ 261,894 $ 231,839
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet05.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
In Millions, except Share data in Thousands, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Accounts receivable, allowances $ 87 $ 86
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 12,600,000 12,600,000
Common stock, shares issued 5,826,419 5,866,161
Common stock, shares outstanding 5,826,419 5,866,161
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet06.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Cash and cash equivalents, beginning of the period $ 13,844 $ 14,259
Operating activities:
Net income 18,024 13,072
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization 2,575 2,144
Share-based compensation expense 888 681
Deferred income tax expense 2,197 1,253
Changes in operating assets and liabilities:
Accounts receivable, net 751 (1,098)
Inventories (172) (358)
Vendor non-trade receivables (3,508) (3,459)
Other current and non-current assets (1,648) (319)
Accounts payable 9,003 8,191
Deferred revenue 945 1,368
Other current and non-current liabilities 4,667 1,195
Cash generated by operating activities 33,722 22,670
Investing activities:
Purchases of marketable securities (44,915) (48,397)
Proceeds from maturities of marketable securities 2,807 5,556
Proceeds from sales of marketable securities 24,166 30,302
Payments made in connection with business acquisitions, net (23) (525)
Payments for acquisition of property, plant and equipment (3,217) (1,985)
Payments for acquisition of intangible assets (48) (59)
Other 65 5
Cash used in investing activities (21,165) (15,103)
Financing activities:
Proceeds from issuance of common stock 80 134
Excess tax benefits from equity awards 264 280
Taxes paid related to net share settlement of equity awards (512) (365)
Dividends and dividend equivalents paid (2,801) (2,769)
Repurchase of common stock (5,030) (5,029)
Proceeds from issuance of long-term debt, net 3,485 0
Repayments of commercial paper, net (2,409) 0
Cash used in financing activities (6,923) (7,749)
Increase/(decrease) in cash and cash equivalents 5,634 (182)
Cash and cash equivalents, end of the period 19,478 14,077
Supplemental cash flow disclosure:
Cash paid for income taxes, net 3,869 3,387
Cash paid for interest $ 202 $ 161
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet07.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Significant Accounting Policies
3 Months Ended
Dec. 27, 2014
Summary of Significant Accounting Policies

Note 1 – Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively “Apple” or the “Company”) designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party iPhone, iPad, Mac and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

Certain prior period amounts in the notes to the condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. In the first quarter of 2015, the Company changed its reportable operating segments and began allocating certain costs to its operating segments that were previously included in other corporate expenses. The Company has reclassified the corresponding prior period amounts to conform to the current period’s presentation as further described in Note 11, “Segment Information and Geographic Data.”

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K (the “2014 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2015 and 2014 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years.

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the three months ended December 27, 2014 and December 28, 2013 (net income in millions and shares in thousands):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Numerator:

     

Net income

   $ 18,024       $ 13,072   

Denominator:

     

Weighted-average shares outstanding

     5,843,082         6,272,504   

Effect of dilutive securities

     38,721         37,657   
  

 

 

    

 

 

 

Weighted-average diluted shares

     5,881,803         6,310,161   
  

 

 

    

 

 

 

Basic earnings per share

   $ 3.08       $ 2.08   

Diluted earnings per share

   $ 3.06       $ 2.07   

Potentially dilutive securities whose effect would have been antidilutive were not significant for the three months ended December 27, 2014 and December 28, 2013. The Company excluded these securities from the computation of diluted earnings per share.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet08.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Financial Instruments
3 Months Ended
Dec. 27, 2014
Financial Instruments

Note 2 – Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                                                           
     December 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 13,757       $ 0       $ 0      $ 13,757       $ 13,757       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     3,346         0         0        3,346         3,346         0         0   

Mutual funds

     2,544         0         (159     2,385         0         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     5,890         0         (159     5,731         3,346         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     35,107         16         (58     35,065         545         692         33,828   

U.S. agency securities

     6,788         2         (11     6,779         582         291         5,906   

Non-U.S. government securities

     6,498         58         (105     6,451         0         177         6,274   

Certificates of deposit and time deposits

     2,778         0         0        2,778         272         1,168         1,338   

Commercial paper

     1,159         0         0        1,159         879         280         0   

Corporate securities

     92,371         159         (720     91,810         97         7,932         83,781   

Municipal securities

     939         4         (1     942         0         0         942   

Mortgage- and asset-backed securities

     13,501         32         (50     13,483         0         60         13,423   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     159,141         271         (945     158,467         2,375         10,600         145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 178,788       $ 271       $ (1,104   $ 177,955       $ 19,478       $ 12,985       $ 145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
     September 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 10,232       $ 0       $ 0      $ 10,232       $ 10,232       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     1,546         0         0        1,546         1,546         0         0   

Mutual funds

     2,531         1         (132     2,400         0         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     4,077         1         (132     3,946         1,546         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     23,140         15         (9     23,146         12         607         22,527   

U.S. agency securities

     7,373         3         (11     7,365         652         157         6,556   

Non-U.S. government securities

     6,925         69         (69     6,925         0         204         6,721   

Certificates of deposit and time deposits

     3,832         0         0        3,832         1,230         1,233         1,369   

Commercial paper

     475         0         0        475         166         309         0   

Corporate securities

     85,431         296         (241     85,486         6         6,298         79,182   

Municipal securities

     940         8         0        948         0         0         948   

Mortgage- and asset-backed securities

     12,907         26         (49     12,884         0         25         12,859   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     141,023         417         (379     141,061         2,066         8,833         130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 155,332       $ 418       $ (511   $ 155,239       $ 13,844       $ 11,233       $ 130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1) 

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

 

 

  (2) 

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

 

The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three months ended December 27, 2014 and December 28, 2013. The maturities of the Company’s long-term marketable securities generally range from one to five years.

As of December 27, 2014 and September 27, 2014, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

As of December 27, 2014, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. During the three months ended December 27, 2014 and December 28, 2013, the Company did not recognize any significant impairment charges.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges.

The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.

The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of December 27, 2014 are expected to be recognized within twelve years.

Cash Flow Hedges

The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized.

The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

 

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 27, 2014 and December 28, 2013.

Net Investment Hedges

The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

Fair Value Hedges

Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. The ineffective portions and amounts excluded from the effectiveness testing of fair value hedges recognized were not significant during the three months ended December 27, 2014 and December 28, 2013.

Non-Designated Derivatives

Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The net gains and losses recognized for foreign currency forward and option contracts not designated as hedging instruments was not significant during the three months ended December 27, 2014 and December 28, 2013.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company’s derivative instruments at gross fair value as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                          
     December 27, 2014  
     Fair Value of
Derivatives
Designated as
Hedge Instruments
     Fair Value of
Derivatives Not
Designated as
Hedge Instruments
     Total
Fair Value
 

Derivative assets (1):

  

Foreign exchange contracts

   $ 3,561       $ 501       $ 4,062   

Interest rate contracts

   $ 201       $ 0       $ 201   
        

Derivative liabilities (2):

        

Foreign exchange contracts

   $ 51       $ 119       $ 170   

Interest rate contracts

   $ 87       $ 0       $ 87   
     September 27, 2014  
     Fair Value of
Derivatives
Designated as
Hedge Instruments
     Fair Value of
Derivatives Not
Designated as
Hedge Instruments
     Total
Fair Value
 

Derivative assets (1):

  

Foreign exchange contracts

   $ 1,332       $ 222       $ 1,554   

Interest rate contracts

   $ 81       $ 0       $ 81   
        

Derivative liabilities (2):

        

Foreign exchange contracts

   $ 41       $ 40       $ 81   

 

  (1) 

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.

 

 

  (2) 

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

 

 

The following tables show the pre-tax effect of the Company’s derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                                                   
     Gains/(Losses)
Recognized in OCI –
Effective Portion
     Gains/(Losses)
Reclassified from AOCI
into Net Income –
Effective Portion
 
     Three Months Ended      Three Months Ended  
     December 27,
2014
    December 28,
2013
     December 27,
2014
    December 28,
2013
 

Cash flow hedges:

  

Foreign exchange contracts

   $ 2,585      $ 264       $ 762      $ (74

Interest rate contracts

     (88     21         (99     (4
  

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 2,497      $ 285       $ 663      $ (78
  

 

 

   

 

 

    

 

 

   

 

 

 

Net investment hedges:

  

Foreign exchange contracts

   $ 118      $ 24       $ 0      $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

 
     Gains/(Losses) on
Derivative
Instruments
     Gains/(Losses)
Related to
Hedged Items
 
     Three Months Ended      Three Months Ended  
     December 27,
2014
    December 28,
2013
     December 27,
2014
    December 28,
2013
 

Fair value hedges:

  

Interest rate contracts

   $ 117      $ 0       $ (117   $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

 

The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                   
     December 27, 2014      September 27, 2014  
     Notional
Amount
     Credit Risk
Amounts
     Notional
Amount
     Credit Risk
Amounts
 

Instruments designated as accounting hedges:

           

Foreign exchange contracts

   $ 55,761       $ 3,561       $ 42,945       $ 1,333   

Interest rate contracts

   $ 15,513       $ 201       $ 12,000       $ 89   
           

Instruments not designated as accounting hedges:

           

Foreign exchange contracts

   $ 39,872       $ 501       $ 38,510       $ 222   

The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

 

The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values in its Condensed Consolidated Balance Sheets. As of December 27, 2014 and September 27, 2014, the Company received $4.2 billion and $2.1 billion, respectively, of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as other current liabilities within accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of December 27, 2014 and September 27, 2014.

Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. As of December 27, 2014 and September 27, 2014, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $4.2 billion and $1.6 billion, respectively, resulting in net derivative liabilities of $184 million and $549 million, respectively.

Accounts Receivable

Trade Receivables

The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, value-added resellers, small and mid-sized businesses and education, enterprise and government customers that are not covered by collateral, third-party financing arrangements or credit insurance. As of December 27, 2014, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 13%. As of September 27, 2014, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 16% and the other 13%. The Company’s cellular network carriers accounted for 63% and 72% of trade receivables as of December 27, 2014 and September 27, 2014, respectively.

Vendor Non-Trade Receivables

Additionally, the Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. Vendor non-trade receivables from three of the Company’s vendors accounted for 57%, 14% and 12% of total vendor non-trade receivables as of December 27, 2014 and three of the Company’s vendors accounted for 51%, 16% and 14% of total vendor non-trade receivables as of September 27, 2014.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet09.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Condensed Consolidated Financial Statement Details
3 Months Ended
Dec. 27, 2014
Condensed Consolidated Financial Statement Details

Note 3 – Condensed Consolidated Financial Statement Details

The following tables show the Company’s condensed consolidated financial statement details as of December 27, 2014 and September 27, 2014 (in millions):

Inventories

 

                                                                 
     December 27, 2014      September 27, 2014  

Components

   $ 228       $ 471   

Finished goods

     2,055         1,640   
  

 

 

    

 

 

 

Total inventories

   $ 2,283       $ 2,111   
  

 

 

    

 

 

 

Property, Plant and Equipment, Net

 

                                                                 
     December 27, 2014     September 27, 2014  

Land and buildings

   $ 5,152      $ 4,863   

Machinery, equipment and internal-use software

     31,010        29,639   

Leasehold improvements

     4,585        4,513   
  

 

 

   

 

 

 

Gross property, plant and equipment

     40,747        39,015   

Accumulated depreciation and amortization

     (20,355     (18,391
  

 

 

   

 

 

 

Total property, plant and equipment, net

   $ 20,392      $ 20,624   
  

 

 

   

 

 

 

 

Accrued Expenses

 

                                                                 
     December 27, 2014      September 27, 2014  

Accrued warranty and related costs

   $ 5,195       $ 4,159   

Accrued marketing and selling expenses

     1,960         2,321   

Accrued taxes

     1,642         1,209   

Accrued compensation and employee benefits

     1,316         1,209   

Deferred margin on component sales

     1,133         1,057   

Other current liabilities

     11,478         8,498   
  

 

 

    

 

 

 

Total accrued expenses

   $ 22,724       $ 18,453   
  

 

 

    

 

 

 

Other Non-Current Liabilities

 

                                                                 
     December 27, 2014      September 27, 2014  

Deferred tax liabilities

   $ 23,371       $ 20,259   

Other non-current liabilities

     5,600         4,567   
  

 

 

    

 

 

 

Total other non-current liabilities

   $ 28,971       $ 24,826   
  

 

 

    

 

 

 

Other Income/(Expense), Net

The following table shows the detail of other income/(expense), net for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                 
     Three Months Ended  
     December 27, 2014     December 28, 2013  

Interest and dividend income

   $ 654      $ 427   

Interest expense

     (131     (84

Other expense, net

     (353     (97
  

 

 

   

 

 

 

Total other income/(expense), net

   $ 170      $ 246   
  

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet10.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Goodwill and Other Intangible Assets
3 Months Ended
Dec. 27, 2014
Goodwill and Other Intangible Assets

Note 4 – Goodwill and Other Intangible Assets

The Company’s acquired intangible assets with definite useful lives primarily consist of patents and licenses and are amortized over periods typically from three to seven years. The following table summarizes the components of gross and net intangible asset balances as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                           
     December 27, 2014      September 27, 2014  
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
 

Definite-lived and amortizable acquired intangible assets

   $ 7,641       $ (3,371   $ 4,270       $ 7,127       $ (3,085   $ 4,042   

Indefinite-lived and non-amortizable acquired intangible assets

     100         0        100         100         0        100   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total acquired intangible assets

   $ 7,741       $ (3,371   $ 4,370       $ 7,227       $ (3,085   $ 4,142   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet11.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Income Taxes
3 Months Ended
Dec. 27, 2014
Income Taxes

Note 5 – Income Taxes

As of December 27, 2014, the Company recorded gross unrecognized tax benefits of $4.4 billion, of which $1.6 billion, if recognized, would affect the Company’s effective tax rate. As of September 27, 2014, the total amount of gross unrecognized tax benefits was $4.0 billion, of which $1.4 billion, if recognized, would have affected the Company’s effective tax rate. The Company’s total gross unrecognized tax benefits are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. The Company had $821 million and $630 million of gross interest and penalties accrued as of December 27, 2014 and September 27, 2014, respectively, which are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets.

Management believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Although timing of the resolution and/or closure of audits is not certain, the Company does not believe it is reasonably possible that its unrecognized tax benefits would materially change in the next 12 months.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet12.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Debt
3 Months Ended
Dec. 27, 2014
Debt

Note 6 – Debt

Commercial Paper

In April 2014, the Board of Directors authorized the Company to issue unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company intends to use net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of December 27, 2014 and September 27, 2014, the Company had $3.9 billion and $6.3 billion of Commercial Paper outstanding, respectively, with a weighted-average interest rate of 0.11% and 0.12%, respectively, and maturities generally less than nine months.

The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the three months ended December 27, 2014 (in millions):

 

Maturities less than 90 days:

Proceeds from (repayments of) commercial paper, net

$ 62   

Maturities greater than 90 days:

Proceeds from commercial paper

  197   

Repayments of commercial paper

  (2,668
  

 

 

 

Maturities greater than 90 days, net

  (2,471
  

 

 

 

Total repayments of commercial paper, net

$ (2,409
  

 

 

 

 

Long-Term Debt

As of December 27, 2014, the Company has issued floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $32.4 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the domestic floating-rate notes, semi-annually for the domestic fixed-rate notes and annually for the foreign fixed-rate notes.

The following table provides a summary of the Company’s long-term debt as of December 27, 2014 and September 27, 2014:

 

     December 27, 2014      September 27, 2014  
     Amount
(in millions)
    Effective
Interest Rate
     Amount
(in millions)
    Effective
Interest Rate
 

Floating-rate notes due 2016 (1)

   $ 1,000        0.51%       $ 1,000        0.51%   

Floating-rate notes due 2017 (2)

     1,000        0.30%         1,000        0.31%   

Floating-rate notes due 2018 (1)

     2,000        1.10%         2,000        1.10%   

Floating-rate notes due 2019 (2)

     1,000        0.53%         1,000        0.54%   

Fixed-rate 0.45% notes due 2016 (1)

     1,500        0.51%         1,500        0.51%   

Fixed-rate 1.05% notes due 2017 (2)

     1,500        0.30%         1,500        0.30%   

Fixed-rate 1.00% notes due 2018 (1)

     4,000        1.08%         4,000        1.08%   

Fixed-rate 2.10% notes due 2019 (2)

     2,000        0.53%         2,000        0.53%   

Fixed-rate 2.85% notes due 2021 (2)

     3,000        0.78%         3,000        0.79%   

Fixed-rate 1.00% Euro-denominated notes due 2022 (3)

     1,709        2.94%         0        0   

Fixed-rate 2.40% notes due 2023 (1)

     5,500        2.44%         5,500        2.44%   

Fixed-rate 3.45% notes due 2024 (2)

     2,500        0.89%         2,500        0.90%   

Fixed-rate 1.63% Euro-denominated notes due 2026 (3)

     1,709        3.45%         0        0   

Fixed-rate 3.85% notes due 2043 (1)

     3,000        3.91%         3,000        3.91%   

Fixed-rate 4.45% notes due 2044 (2)

     1,000        4.48%         1,000        4.48%   
  

 

 

      

 

 

   

Total borrowings

     32,418           29,000     
  

 

 

      

 

 

   

Unamortized discount

     (69        (52  

Hedge accounting fair value adjustments

     155           39     
  

 

 

      

 

 

   

Total long-term debt

   $ 32,504         $ 28,987     
  

 

 

      

 

 

   

 

  (1)

Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013.

 

 

  (2) 

Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014.

 

 

  (3) 

Tranche relates to Euro-denominated debt issuance of 2.8 billion in the first quarter of 2015.

 

The Company has entered, and in the future may enter, into interest rate swaps to manage interest rate risk on the Notes. Such swaps allow the Company to effectively convert fixed-rate payments into floating-rate payments or floating-rate payments into fixed-rate payments. In addition, the Company has entered, and in the future may enter, into currency swaps to manage foreign currency risk on the Notes.

In the first quarter of 2015, the Company issued 2.8 billion of Euro-denominated long-term debt. To manage foreign currency risk associated with this issuance, the Company entered into currency swaps with an aggregate notional amount of $3.5 billion, which effectively converted the Euro-denominated notes to U.S. dollar-denominated notes.

The effective rates for the Notes include the interest on the Notes, amortization of the discount and, if applicable, adjustments related to hedging. The Company recognized $128 million and $84 million of interest expense on its long-term debt for the three months ended December 27, 2014 and December 28, 2013, respectively.

 

Future principal payments for the Company’s Notes as of December 27, 2014 are as follows (in millions):

 

2015

   $ 0   

2016

     2,500   

2017

     2,500   

2018

     6,000   

2019

     3,000   

Thereafter

     18,418   
  

 

 

 

Total future principal payments

   $ 32,418   
  

 

 

 

As of December 27, 2014 and September 27, 2014, the fair value of the Company’s Notes, based on Level 2 inputs, was $32.4 billion and $28.5 billion, respectively.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet13.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Shareholders' Equity
3 Months Ended
Dec. 27, 2014
Shareholders' Equity

Note 7 – Shareholders’ Equity

Dividends

The Company declared and paid cash dividends per common share during the periods presented as follows:

 

     Dividends
Per Share
     Amount
(in millions)
 

2015:

     

First quarter

   $ 0.47       $ 2,750   
     

2014:

     

Fourth quarter

   $ 0.47       $ 2,807   

Third quarter

     0.47         2,830   

Second quarter

     0.44         2,655   

First quarter

     0.44         2,739   
  

 

 

    

 

 

 

Total cash dividends declared and paid

   $ 1.82       $ 11,031   
  

 

 

    

 

 

 

Future dividends are subject to declaration by the Board of Directors.

Share Repurchase Program

In 2014, the Company’s Board of Directors increased the share repurchase authorization to $90 billion of the Company’s common stock. As of December 27, 2014, $72.9 billion of the $90 billion had been utilized. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The Company has entered, and in the future may enter, into accelerated share repurchase arrangements (“ASRs”) with financial institutions. In exchange for up-front payments, the financial institutions deliver shares of the Company’s common stock during the purchase periods of each ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, is determined at the end of the applicable purchase period of each ASR based on the volume weighted-average price of the Company’s common stock during that period. The shares received are retired in the periods they are delivered, and the up-front payments are accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheet in the periods the payments are made. The Company reflects the ASRs as a repurchase of common stock in the period delivered for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. The ASRs met all of the applicable criteria for equity classification, and therefore, were not accounted for as derivative instruments.

 

A summary of the Company’s ASR activity and related information during the periods presented, is as follows:

 

     Purchase
Period End
Date
     Number of
Shares
(in thousands)
     Average
Repurchase
Price
Per Share
     ASR
Amount
(in millions)
 

August 2014 ASR

          (1)         68,273 (1)              (1)       $ 9,000   

January 2014 ASR

     December 2014            134,247           $ 89.39          $ 12,000   

April 2013 ASR

     March 2014            172,548           $ 69.55          $ 12,000   

 

  (1) 

Includes 8.3 million net shares delivered and retired under the August 2014 ASR in the first quarter of 2015. “Number of Shares” represents those shares delivered in advance of settlement and does not represent the final number of shares to be delivered under the ASRs. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company’s common stock during that period. The August 2014 ASR purchase period will end in or before February 2015.

 

Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows:

 

     Number of
Shares

(in thousands)
     Average
Repurchase
Price

Per Share
     Amount
(in millions)
 

2015:

        

First quarter

     45,704       $ 109.40       $ 5,000   
        

2014:

        

Fourth quarter

     81,255       $ 98.46       $ 8,000   

Third quarter

     58,661       $ 85.23         5,000   

Second quarter

     79,749       $ 75.24         6,000   

First quarter

     66,847       $ 74.79         5,000   
  

 

 

       

 

 

 

Total open market common stock repurchases

     286,512          $ 24,000   
  

 

 

       

 

 

 

 

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet14.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Comprehensive Income
3 Months Ended
Dec. 27, 2014
Comprehensive Income

Note 8 – Comprehensive Income

Comprehensive income consists of two components, net income and OCI. OCI refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s OCI consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and unrealized gains and losses on marketable securities classified as available-for-sale.

The following table shows the gross amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations and the associated financial statement line item, for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                          

Comprehensive Income Components

 

Financial Statement Line Item

   December 27,
2014
    December 28,
2013
 

Unrecognized gains/losses on derivative instruments:

      

Foreign exchange contracts

  Revenue    $ (449   $ 184   
  Cost of sales      (313     (110
  Other income/expense, net      0        10   

Interest rate contracts

  Other income/expense, net      99        4   
    

 

 

   

 

 

 
       (663     88   

Unrealized gains/losses on marketable securities

  Other income/expense, net      (22     (17
    

 

 

   

 

 

 

Total amounts reclassified from AOCI

     $ (685   $ 71   
    

 

 

   

 

 

 

The following table shows the changes in AOCI by component for the three months ended December 27, 2014 (in millions):

 

                                                                                                   
     Cumulative
Foreign
Currency
Translation
    Unrecognized
Gains/Losses
on Derivative
Instruments
    Unrealized
Gains/Losses
on Marketable
Securities
    Total  

Balance at September 27, 2014

   $ (242   $ 1,364      $ (40   $ 1,082   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income/(loss) before reclassifications

     (114     2,390        (707     1,569   

Amounts reclassified from AOCI

     0        (663     (22     (685

Tax effect

     48        (310     259        (3
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income/(loss)

     (66     1,417        (470     881   
  

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 27, 2014

   $ (308   $ 2,781      $ (510   $ 1,963   
  

 

 

   

 

 

   

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet15.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Benefit Plans
3 Months Ended
Dec. 27, 2014
Benefit Plans

Note 9 – Benefit Plans

Stock Plans

The Company had 436.9 million shares reserved for future issuance under its stock plans as of December 27, 2014. RSUs granted generally vest over four years, based on continued employment, and are settled upon vesting in shares of the Company’s common stock on a one-for-one basis. Each share issued with respect to RSUs granted under the Company’s stock plans reduces the number of shares available for grant under the plan by two shares. RSUs cancelled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant under the plans utilizing a factor of two times the number of RSUs cancelled or shares withheld. Stock options count against the number of shares available for grant on a one-for-one basis.

Rule 10b5-1 Trading Plans

During the three months ended December 27, 2014, Section 16 officers Timothy D. Cook, Angela Ahrendts, Luca Maestri and Daniel Riccio had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans.

 

Restricted Stock Units

A summary of the Company’s RSU activity and related information for the three months ended December 27, 2014, is as follows:

 

                                                                          
     Number of
RSUs
(in thousands)
     Weighted-Average
Grant Date Fair
Value
     Aggregate
Intrinsic Value
(in millions)
 

Balance at September 27, 2014

     103,822       $ 70.98      

RSUs granted

     36,294       $ 101.41      

RSUs vested

     (16,759    $ 64.30      

RSUs cancelled

     (1,815    $ 71.49      
  

 

 

       

Balance at December 27, 2014

  121,542    $ 80.98    $ 13,855   
  

 

 

       

RSUs that vested during the three months ended December 27, 2014 and December 28, 2013 had a fair value of $1.7 billion and $1.1 billion, respectively, as of the vesting date.

Stock Options

The Company had 3.5 million stock options outstanding as of December 27, 2014, with a weighted average exercise price per share of $19.61 and weighted average remaining contractual term of 2.2 years, substantially all of which are exercisable. The aggregate intrinsic value of the stock options outstanding as of December 27, 2014 was $330 million, which represents the value of the Company’s closing stock price on the last trading day of the period in excess of the weighted-average exercise price multiplied by the number of options outstanding.

The total intrinsic value of options at the time of exercise was $248 million and $559 million for the three months ended December 27, 2014 and December 28, 2013, respectively.

Share-Based Compensation

The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Cost of sales

   $ 140       $ 109   

Research and development

     374         289   

Selling, general and administrative

     374         283   
  

 

 

    

 

 

 

Total share-based compensation expense

$ 888    $ 681   
  

 

 

    

 

 

 

The income tax benefit related to share-based compensation expense was $351 million and $265 million for the three months ended December 27, 2014 and December 28, 2013, respectively. As of December 27, 2014, the total unrecognized compensation cost related to outstanding stock options and RSUs expected to vest was $8.8 billion, which the Company expects to recognize over a weighted-average period of 3.1 years.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet16.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Commitments and Contingencies
3 Months Ended
Dec. 27, 2014
Commitments and Contingencies

Note 10 – Commitments and Contingencies

Accrued Warranty and Indemnification

The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
    December 28,
2013
 

Beginning accrued warranty and related costs

   $ 4,159      $ 2,967   

Cost of warranty claims

     (1,044     (1,064

Accruals for product warranty

     2,080        2,077   
  

 

 

   

 

 

 

Ending accrued warranty and related costs

   $ 5,195      $ 3,980   
  

 

 

   

 

 

 

The Company generally does not indemnify end-users of its operating system and application software against legal claims that the software infringes third-party intellectual property rights. Other agreements entered into by the Company sometimes include indemnification provisions under which the Company could be subject to costs and/or damages in the event of an infringement claim against the Company or an indemnified third-party. However, the Company has not been required to make any significant payments resulting from such an infringement claim asserted against it or an indemnified third-party. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss with respect to indemnification of end-users of its operating system or application software for infringement of third-party intellectual property rights. The Company did not record a liability for infringement costs related to indemnification as of December 27, 2014 or September 27, 2014.

The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. However, the Company maintains directors and officers liability insurance coverage to reduce its exposure to such obligations, and payments made under these agreements historically have not been material.

Concentrations in the Available Sources of Supply of Materials and Product

Although most components essential to the Company’s business are generally available from multiple sources, a number of components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that could materially adversely affect the Company’s financial condition and operating results.

The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers concentrated on the production of common components instead of components customized to meet the Company’s requirements.

The Company has entered into agreements for the supply of many components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that could materially adversely affect its financial condition and operating results.

 

Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are the sole-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s operating results could be adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s purchase commitments typically cover its requirements for periods up to 150 days.

Other Off-Balance Sheet Commitments

Operating Leases

The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The Company does not currently utilize any other off-balance sheet financing arrangements. The major facility leases are typically for terms not exceeding 10 years and generally contain multi-year renewal options. As of December 27, 2014, the Company had a total of 447 retail stores. Leases for retail space are for terms ranging from five to 20 years, the majority of which are for 10 years, and often contain multi-year renewal options. As of December 27, 2014, the Company’s total future minimum lease payments under noncancelable operating leases were $4.8 billion, of which $3.5 billion related to leases for retail space.

Other Commitments

The Company utilizes several outsourcing partners to manufacture sub-assemblies for the Company’s products and to perform final assembly and testing of finished products. These outsourcing partners acquire components and build product based on demand information supplied by the Company, which typically covers periods up to 150 days. The Company also obtains individual components for its products from a wide variety of individual suppliers. Consistent with industry practice, the Company acquires components through a combination of purchase orders, supplier contracts and open orders based on projected demand information. Where appropriate, the purchases are applied to inventory component prepayments that are outstanding with the respective supplier. As of December 27, 2014, the Company had outstanding off-balance sheet third-party manufacturing commitments and component purchase commitments of $21.6 billion.

In addition to the commitments mentioned above, the Company had other off-balance sheet obligations of $3.9 billion as of December 27, 2014, which were comprised of commitments to acquire capital assets, including product tooling and manufacturing process equipment, and commitments related to advertising, research and development (“R&D”), Internet and telecommunications services, energy and other obligations.

Contingencies

The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, certain of which are discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies. However, the outcome of litigation is inherently uncertain. Therefore, although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected.

Apple Inc. v. Samsung Electronics Co., Ltd, et al.

On August 24, 2012, a jury returned a verdict awarding the Company $1.05 billion in its lawsuit against Samsung Electronics Co., Ltd and affiliated parties in the United States District Court, Northern District of California, San Jose Division. On March 6, 2014, the District Court entered final judgment in favor of the Company in the amount of approximately $930 million. Because the award is now subject to appeal, the Company has not recognized the award in its results of operations.

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet17.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Segment Information and Geographic Data
3 Months Ended
Dec. 27, 2014
Segment Information and Geographic Data

Note 11 – Segment Information and Geographic Data

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable operating segments.

The Company manages its business primarily on a geographic basis. As the Company continues to expand its business, management believes collaboration across its online, retail and indirect channels is integral to better serving its customers and optimizing its financial results. In the first quarter of 2015, management began reporting business performance and making decisions primarily on a geographic basis, including the results of its retail stores in each respective geographic segment. Accordingly, to align with the way the business is currently managed, the Company’s reportable operating segments now consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Retail is no longer reported as a separate reportable operating segment. The Americas segment includes both North and South America. The Europe segment includes European countries, as well as India, the Middle East and Africa. The Greater China segment includes China, Hong Kong and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries, other than those countries included in the Company’s other operating segments. Each operating segment provides similar hardware and software products and similar services. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2014 Form 10-K.

The Company evaluates the performance of its operating segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. In the first quarter of 2015, the Company also began allocating certain costs to its operating segments that were previously included in other corporate expenses, including certain share-based compensation costs. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as R&D, corporate marketing expenses, certain share-based compensation expense, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes.

 

The following table shows information by operating segment for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Americas:

     

Net sales

   $ 30,566       $ 24,789   

Operating income

   $ 10,701       $ 8,069   
     

Europe:

     

Net sales

   $ 17,214       $ 14,335   

Operating income

   $ 5,882       $ 4,623   

Greater China:

     

Net sales

   $ 16,144       $ 9,496   

Operating income

   $ 6,366       $ 3,247   
     

Japan:

     

Net sales

   $ 5,448       $ 5,045   

Operating income

   $ 2,488       $ 2,330   

Rest of Asia Pacific:

     

Net sales

   $ 5,227       $ 3,929   

Operating income

   $ 1,849       $ 1,368   

A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 is as follows (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
    December 28,
2013
 

Segment operating income

   $ 27,286      $ 19,637   

Research and development expense

     (1,895     (1,330

Other corporate expenses, net

     (1,145     (844
  

 

 

   

 

 

 

Total operating income

   $ 24,246      $ 17,463   
  

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet18.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Dec. 27, 2014
Basis of Presentation and Preparation

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

Certain prior period amounts in the notes to the condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. In the first quarter of 2015, the Company changed its reportable operating segments and began allocating certain costs to its operating segments that were previously included in other corporate expenses. The Company has reclassified the corresponding prior period amounts to conform to the current period’s presentation as further described in Note 11, “Segment Information and Geographic Data.”

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K (the “2014 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2015 and 2014 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years.

Earnings Per Share

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the three months ended December 27, 2014 and December 28, 2013 (net income in millions and shares in thousands):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Numerator:

     

Net income

   $ 18,024       $ 13,072   

Denominator:

     

Weighted-average shares outstanding

     5,843,082         6,272,504   

Effect of dilutive securities

     38,721         37,657   
  

 

 

    

 

 

 

Weighted-average diluted shares

     5,881,803         6,310,161   
  

 

 

    

 

 

 

Basic earnings per share

   $ 3.08       $ 2.08   

Diluted earnings per share

   $ 3.06       $ 2.07   

Potentially dilutive securities whose effect would have been antidilutive were not significant for the three months ended December 27, 2014 and December 28, 2013. The Company excluded these securities from the computation of diluted earnings per share.

Derivative Financial Instruments

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges.

The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.

The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of December 27, 2014 are expected to be recognized within twelve years.

Cash Flow Hedges

The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized.

The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

 

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 27, 2014 and December 28, 2013.

Net Investment Hedges

The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

Fair Value Hedges

Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. The ineffective portions and amounts excluded from the effectiveness testing of fair value hedges recognized were not significant during the three months ended December 27, 2014 and December 28, 2013.

Non-Designated Derivatives

Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The net gains and losses recognized for foreign currency forward and option contracts not designated as hedging instruments was not significant during the three months ended December 27, 2014 and December 28, 2013

------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet19.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 27, 2014
Computation of Basic and Diluted Earnings Per Share

The following table shows the computation of basic and diluted earnings per share for the three months ended December 27, 2014 and December 28, 2013 (net income in millions and shares in thousands):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Numerator:

     

Net income

   $ 18,024       $ 13,072   

Denominator:

     

Weighted-average shares outstanding

     5,843,082         6,272,504   

Effect of dilutive securities

     38,721         37,657   
  

 

 

    

 

 

 

Weighted-average diluted shares

     5,881,803         6,310,161   
  

 

 

    

 

 

 

Basic earnings per share

   $ 3.08       $ 2.08   

Diluted earnings per share

   $ 3.06       $ 2.07   
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet20.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Financial Instruments (Tables)
3 Months Ended
Dec. 27, 2014
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities

The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                                                           
     December 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 13,757       $ 0       $ 0      $ 13,757       $ 13,757       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     3,346         0         0        3,346         3,346         0         0   

Mutual funds

     2,544         0         (159     2,385         0         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     5,890         0         (159     5,731         3,346         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     35,107         16         (58     35,065         545         692         33,828   

U.S. agency securities

     6,788         2         (11     6,779         582         291         5,906   

Non-U.S. government securities

     6,498         58         (105     6,451         0         177         6,274   

Certificates of deposit and time deposits

     2,778         0         0        2,778         272         1,168         1,338   

Commercial paper

     1,159         0         0        1,159         879         280         0   

Corporate securities

     92,371         159         (720     91,810         97         7,932         83,781   

Municipal securities

     939         4         (1     942         0         0         942   

Mortgage- and asset-backed securities

     13,501         32         (50     13,483         0         60         13,423   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     159,141         271         (945     158,467         2,375         10,600         145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 178,788       $ 271       $ (1,104   $ 177,955       $ 19,478       $ 12,985       $ 145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
     September 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 10,232       $ 0       $ 0      $ 10,232       $ 10,232       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     1,546         0         0        1,546         1,546         0         0   

Mutual funds

     2,531         1         (132     2,400         0         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     4,077         1         (132     3,946         1,546         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     23,140         15         (9     23,146         12         607         22,527   

U.S. agency securities

     7,373         3         (11     7,365         652         157         6,556   

Non-U.S. government securities

     6,925         69         (69     6,925         0         204         6,721   

Certificates of deposit and time deposits

     3,832         0         0        3,832         1,230         1,233         1,369   

Commercial paper

     475         0         0        475         166         309         0   

Corporate securities

     85,431         296         (241     85,486         6         6,298         79,182   

Municipal securities

     940         8         0        948         0         0         948   

Mortgage- and asset-backed securities

     12,907         26         (49     12,884         0         25         12,859   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     141,023         417         (379     141,061         2,066         8,833         130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 155,332       $ 418       $ (511   $ 155,239       $ 13,844       $ 11,233       $ 130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1) 

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

 

 

  (2) 

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities

The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                                                           
     December 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 13,757       $ 0       $ 0      $ 13,757       $ 13,757       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     3,346         0         0        3,346         3,346         0         0   

Mutual funds

     2,544         0         (159     2,385         0         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     5,890         0         (159     5,731         3,346         2,385         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     35,107         16         (58     35,065         545         692         33,828   

U.S. agency securities

     6,788         2         (11     6,779         582         291         5,906   

Non-U.S. government securities

     6,498         58         (105     6,451         0         177         6,274   

Certificates of deposit and time deposits

     2,778         0         0        2,778         272         1,168         1,338   

Commercial paper

     1,159         0         0        1,159         879         280         0   

Corporate securities

     92,371         159         (720     91,810         97         7,932         83,781   

Municipal securities

     939         4         (1     942         0         0         942   

Mortgage- and asset-backed securities

     13,501         32         (50     13,483         0         60         13,423   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     159,141         271         (945     158,467         2,375         10,600         145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 178,788       $ 271       $ (1,104   $ 177,955       $ 19,478       $ 12,985       $ 145,492   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
     September 27, 2014  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
     Cash and
Cash
Equivalents
     Short-Term
Marketable
Securities
     Long-Term
Marketable
Securities
 

Cash

   $ 10,232       $ 0       $ 0      $ 10,232       $ 10,232       $ 0       $ 0   
                   

Level 1 (1):

                   

Money market funds

     1,546         0         0        1,546         1,546         0         0   

Mutual funds

     2,531         1         (132     2,400         0         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     4,077         1         (132     3,946         1,546         2,400         0   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Level 2 (2):

                   

U.S. Treasury securities

     23,140         15         (9     23,146         12         607         22,527   

U.S. agency securities

     7,373         3         (11     7,365         652         157         6,556   

Non-U.S. government securities

     6,925         69         (69     6,925         0         204         6,721   

Certificates of deposit and time deposits

     3,832         0         0        3,832         1,230         1,233         1,369   

Commercial paper

     475         0         0        475         166         309         0   

Corporate securities

     85,431         296         (241     85,486         6         6,298         79,182   

Municipal securities

     940         8         0        948         0         0         948   

Mortgage- and asset-backed securities

     12,907         26         (49     12,884         0         25         12,859   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal

     141,023         417         (379     141,061         2,066         8,833         130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 
                   

Total

   $ 155,332       $ 418       $ (511   $ 155,239       $ 13,844       $ 11,233       $ 130,162   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1) 

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

 

 

  (2) 

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 
Derivative Instruments at Gross Fair Value

The following tables show the Company’s derivative instruments at gross fair value as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                          
     December 27, 2014  
     Fair Value of
Derivatives
Designated as
Hedge Instruments
     Fair Value of
Derivatives Not
Designated as
Hedge Instruments
     Total
Fair Value
 

Derivative assets (1):

  

Foreign exchange contracts

   $ 3,561       $ 501       $ 4,062   

Interest rate contracts

   $ 201       $ 0       $ 201   
        

Derivative liabilities (2):

        

Foreign exchange contracts

   $ 51       $ 119       $ 170   

Interest rate contracts

   $ 87       $ 0       $ 87   
     September 27, 2014  
     Fair Value of
Derivatives
Designated as
Hedge Instruments
     Fair Value of
Derivatives Not
Designated as
Hedge Instruments
     Total
Fair Value
 

Derivative assets (1):

  

Foreign exchange contracts

   $ 1,332       $ 222       $ 1,554   

Interest rate contracts

   $ 81       $ 0       $ 81   
        

Derivative liabilities (2):

        

Foreign exchange contracts

   $ 41       $ 40       $ 81   

 

  (1) 

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.

 

 

  (2) 

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

 
Pre-Tax Effect of Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges

The following tables show the pre-tax effect of the Company’s derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                                                   
     Gains/(Losses)
Recognized in OCI –
Effective Portion
     Gains/(Losses)
Reclassified from AOCI
into Net Income –
Effective Portion
 
     Three Months Ended      Three Months Ended  
     December 27,
2014
    December 28,
2013
     December 27,
2014
    December 28,
2013
 

Cash flow hedges:

  

Foreign exchange contracts

   $ 2,585      $ 264       $ 762      $ (74

Interest rate contracts

     (88     21         (99     (4
  

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 2,497      $ 285       $ 663      $ (78
  

 

 

   

 

 

    

 

 

   

 

 

 

Net investment hedges:

  

Foreign exchange contracts

   $ 118      $ 24       $ 0      $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

 
     Gains/(Losses) on
Derivative
Instruments
     Gains/(Losses)
Related to
Hedged Items
 
     Three Months Ended      Three Months Ended  
     December 27,
2014
    December 28,
2013
     December 27,
2014
    December 28,
2013
 

Fair value hedges:

  

Interest rate contracts

   $ 117      $ 0       $ (117   $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

 
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments

The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                   
     December 27, 2014      September 27, 2014  
     Notional
Amount
     Credit Risk
Amounts
     Notional
Amount
     Credit Risk
Amounts
 

Instruments designated as accounting hedges:

           

Foreign exchange contracts

   $ 55,761       $ 3,561       $ 42,945       $ 1,333   

Interest rate contracts

   $ 15,513       $ 201       $ 12,000       $ 89   
           

Instruments not designated as accounting hedges:

           

Foreign exchange contracts

   $ 39,872       $ 501       $ 38,510       $ 222   
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet21.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Condensed Consolidated Financial Statement Details (Tables)
3 Months Ended
Dec. 27, 2014
Inventories

Inventories

 

                                                                 
     December 27, 2014      September 27, 2014  

Components

   $ 228       $ 471   

Finished goods

     2,055         1,640   
  

 

 

    

 

 

 

Total inventories

   $ 2,283       $ 2,111   
  

 

 

    

 

 

 
Property, Plant and Equipment, Net

Property, Plant and Equipment, Net

 

                                                                 
     December 27, 2014     September 27, 2014  

Land and buildings

   $ 5,152      $ 4,863   

Machinery, equipment and internal-use software

     31,010        29,639   

Leasehold improvements

     4,585        4,513   
  

 

 

   

 

 

 

Gross property, plant and equipment

     40,747        39,015   

Accumulated depreciation and amortization

     (20,355     (18,391
  

 

 

   

 

 

 

Total property, plant and equipment, net

   $ 20,392      $ 20,624   
  

 

 

   

 

 

 
Accrued Expenses

Accrued Expenses

 

                                                                 
     December 27, 2014      September 27, 2014  

Accrued warranty and related costs

   $ 5,195       $ 4,159   

Accrued marketing and selling expenses

     1,960         2,321   

Accrued taxes

     1,642         1,209   

Accrued compensation and employee benefits

     1,316         1,209   

Deferred margin on component sales

     1,133         1,057   

Other current liabilities

     11,478         8,498   
  

 

 

    

 

 

 

Total accrued expenses

   $ 22,724       $ 18,453   
  

 

 

    

 

 

 
Other Non-Current Liabilities

Other Non-Current Liabilities

 

                                                                 
     December 27, 2014      September 27, 2014  

Deferred tax liabilities

   $ 23,371       $ 20,259   

Other non-current liabilities

     5,600         4,567   
  

 

 

    

 

 

 

Total other non-current liabilities

   $ 28,971       $ 24,826   
  

 

 

    

 

 

 
Other Income/(Expense), Net

Other Income/(Expense), Net

The following table shows the detail of other income/(expense), net for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                 
     Three Months Ended  
     December 27, 2014     December 28, 2013  

Interest and dividend income

   $ 654      $ 427   

Interest expense

     (131     (84

Other expense, net

     (353     (97
  

 

 

   

 

 

 

Total other income/(expense), net

   $ 170      $ 246   
  

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet22.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Goodwill and Other Intangible Assets (Tables)
3 Months Ended
Dec. 27, 2014
Components of Gross and Net Intangible Asset Balances

The following table summarizes the components of gross and net intangible asset balances as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                           
     December 27, 2014      September 27, 2014  
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
 

Definite-lived and amortizable acquired intangible assets

   $ 7,641       $ (3,371   $ 4,270       $ 7,127       $ (3,085   $ 4,042   

Indefinite-lived and non-amortizable acquired intangible assets

     100         0        100         100         0        100   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total acquired intangible assets

   $ 7,741       $ (3,371   $ 4,370       $ 7,227       $ (3,085   $ 4,142   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 
Components of Gross and Net Intangible Asset Balances

The following table summarizes the components of gross and net intangible asset balances as of December 27, 2014 and September 27, 2014 (in millions):

 

                                                                                                           
     December 27, 2014      September 27, 2014  
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Carrying
Amount
 

Definite-lived and amortizable acquired intangible assets

   $ 7,641       $ (3,371   $ 4,270       $ 7,127       $ (3,085   $ 4,042   

Indefinite-lived and non-amortizable acquired intangible assets

     100         0        100         100         0        100   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total acquired intangible assets

   $ 7,741       $ (3,371   $ 4,370       $ 7,227       $ (3,085   $ 4,142   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet23.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Debt (Tables)
3 Months Ended
Dec. 27, 2014
Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper

The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the three months ended December 27, 2014 (in millions):

 

Maturities less than 90 days:

Proceeds from (repayments of) commercial paper, net

$ 62   

Maturities greater than 90 days:

Proceeds from commercial paper

  197   

Repayments of commercial paper

  (2,668
  

 

 

 

Maturities greater than 90 days, net

  (2,471
  

 

 

 

Total repayments of commercial paper, net

$ (2,409
  

 

 

 

Summary of Long-Term Debt

The following table provides a summary of the Company’s long-term debt as of December 27, 2014 and September 27, 2014:

 

                                                                                                   
     December 27, 2014      September 27, 2014  
     Amount
(in millions)
    Effective
Interest Rate
     Amount
(in millions)
    Effective
Interest Rate
 

Floating-rate notes due 2016 (1)

   $ 1,000        0.51%       $ 1,000        0.51%   

Floating-rate notes due 2017 (2)

     1,000        0.30%         1,000        0.31%   

Floating-rate notes due 2018 (1)

     2,000        1.10%         2,000        1.10%   

Floating-rate notes due 2019 (2)

     1,000        0.53%         1,000        0.54%   

Fixed-rate 0.45% notes due 2016 (1)

     1,500        0.51%         1,500        0.51%   

Fixed-rate 1.05% notes due 2017 (2)

     1,500        0.30%         1,500        0.30%   

Fixed-rate 1.00% notes due 2018 (1)

     4,000        1.08%         4,000        1.08%   

Fixed-rate 2.10% notes due 2019 (2)

     2,000        0.53%         2,000        0.53%   

Fixed-rate 2.85% notes due 2021 (2)

     3,000        0.78%         3,000        0.79%   

Fixed-rate 1.00% Euro-denominated notes due 2022 (3)

     1,709        2.94%         0        0   

Fixed-rate 2.40% notes due 2023 (1)

     5,500        2.44%         5,500        2.44%   

Fixed-rate 3.45% notes due 2024 (2)

     2,500        0.89%         2,500        0.90%   

Fixed-rate 1.63% Euro-denominated notes due 2026 (3)

     1,709        3.45%         0        0   

Fixed-rate 3.85% notes due 2043 (1)

     3,000        3.91%         3,000        3.91%   

Fixed-rate 4.45% notes due 2044 (2)

     1,000        4.48%         1,000        4.48%   
  

 

 

      

 

 

   

Total borrowings

     32,418           29,000     
  

 

 

      

 

 

   

Unamortized discount

     (69        (52  

Hedge accounting fair value adjustments

     155           39     
  

 

 

      

 

 

   

Total long-term debt

   $ 32,504         $ 28,987     
  

 

 

      

 

 

   

 

  (1)

Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013.

 

 

  (2) 

Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014.

 

 

  (3) 

Tranche relates to Euro-denominated debt issuance of 2.8 billion in the first quarter of 2015.

 
Future Principal Payments for Notes

Future principal payments for the Company’s Notes as of December 27, 2014 are as follows (in millions):

 

                        

2015

   $ 0   

2016

     2,500   

2017

     2,500   

2018

     6,000   

2019

     3,000   

Thereafter

     18,418   
  

 

 

 

Total future principal payments

   $ 32,418   
  

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet24.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Shareholders' Equity (Tables)
3 Months Ended
Dec. 27, 2014
Cash Dividends Declared and Paid Per Common Share

The Company declared and paid cash dividends per common share during the periods presented as follows:

 

                                                 
     Dividends
Per Share
     Amount
(in millions)
 

2015:

     

First quarter

   $ 0.47       $ 2,750   
     

2014:

     

Fourth quarter

   $ 0.47       $ 2,807   

Third quarter

     0.47         2,830   

Second quarter

     0.44         2,655   

First quarter

     0.44         2,739   
  

 

 

    

 

 

 

Total cash dividends declared and paid

   $ 1.82       $ 11,031   
  

 

 

    

 

 

 
Summary of Accelerated Share Repurchase Activity and Related Information

A summary of the Company’s ASR activity and related information during the periods presented, is as follows:

 

     Purchase
Period End
Date
     Number of
Shares
(in thousands)
     Average
Repurchase
Price
Per Share
     ASR
Amount
(in millions)
 

August 2014 ASR

          (1)         68,273 (1)              (1)       $ 9,000   

January 2014 ASR

     December 2014            134,247           $ 89.39          $ 12,000   

April 2013 ASR

     March 2014            172,548           $ 69.55          $ 12,000   

 

  (1) 

Includes 8.3 million net shares delivered and retired under the August 2014 ASR in the first quarter of 2015. “Number of Shares” represents those shares delivered in advance of settlement and does not represent the final number of shares to be delivered under the ASRs. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company’s common stock during that period. The August 2014 ASR purchase period will end in or before February 2015.

 

Repurchases of Common Shares in Open Market

Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows:

 

                                                                          
     Number of
Shares

(in thousands)
     Average
Repurchase
Price

Per Share
     Amount
(in millions)
 

2015:

        

First quarter

     45,704       $ 109.40       $ 5,000   
        

2014:

        

Fourth quarter

     81,255       $ 98.46       $ 8,000   

Third quarter

     58,661       $ 85.23         5,000   

Second quarter

     79,749       $ 75.24         6,000   

First quarter

     66,847       $ 74.79         5,000   
  

 

 

       

 

 

 

Total open market common stock repurchases

     286,512          $ 24,000   
  

 

 

       

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet25.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Comprehensive Income (Tables)
3 Months Ended
Dec. 27, 2014
Gross Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations

The following table shows the gross amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations and the associated financial statement line item, for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                                          

Comprehensive Income Components

 

Financial Statement Line Item

   December 27,
2014
    December 28,
2013
 

Unrecognized gains/losses on derivative instruments:

      

Foreign exchange contracts

  Revenue    $ (449   $ 184   
  Cost of sales      (313     (110
  Other income/expense, net      0        10   

Interest rate contracts

  Other income/expense, net      99        4   
    

 

 

   

 

 

 
       (663     88   

Unrealized gains/losses on marketable securities

  Other income/expense, net      (22     (17
    

 

 

   

 

 

 

Total amounts reclassified from AOCI

     $ (685   $ 71   
    

 

 

   

 

 

 
Change in Accumulated Other Comprehensive Income by Component

The following table shows the changes in AOCI by component for the three months ended December 27, 2014 (in millions):

 

                                                                                                   
     Cumulative
Foreign
Currency
Translation
    Unrecognized
Gains/Losses
on Derivative
Instruments
    Unrealized
Gains/Losses
on Marketable
Securities
    Total  

Balance at September 27, 2014

   $ (242   $ 1,364      $ (40   $ 1,082   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income/(loss) before reclassifications

     (114     2,390        (707     1,569   

Amounts reclassified from AOCI

     0        (663     (22     (685

Tax effect

     48        (310     259        (3
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income/(loss)

     (66     1,417        (470     881   
  

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 27, 2014

   $ (308   $ 2,781      $ (510   $ 1,963   
  

 

 

   

 

 

   

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet26.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Benefit Plans (Tables)
3 Months Ended
Dec. 27, 2014
Restricted Stock Activity

A summary of the Company’s RSU activity and related information for the three months ended December 27, 2014, is as follows:

 

                                                                          
     Number of
RSUs
(in thousands)
     Weighted-Average
Grant Date Fair
Value
     Aggregate
Intrinsic Value
(in millions)
 

Balance at September 27, 2014

     103,822       $ 70.98      

RSUs granted

     36,294       $ 101.41      

RSUs vested

     (16,759    $ 64.30      

RSUs cancelled

     (1,815    $ 71.49      
  

 

 

       

Balance at December 27, 2014

  121,542    $ 80.98    $ 13,855   
  

 

 

       
Summary of Share-Based Compensation Expense

The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Cost of sales

   $ 140       $ 109   

Research and development

     374         289   

Selling, general and administrative

     374         283   
  

 

 

    

 

 

 

Total share-based compensation expense

$ 888    $ 681   
  

 

 

    

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet27.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Commitments and Contingencies (Tables)
3 Months Ended
Dec. 27, 2014
Changes in Accrued Warranties and Related Costs

The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
    December 28,
2013
 

Beginning accrued warranty and related costs

   $ 4,159      $ 2,967   

Cost of warranty claims

     (1,044     (1,064

Accruals for product warranty

     2,080        2,077   
  

 

 

   

 

 

 

Ending accrued warranty and related costs

   $ 5,195      $ 3,980   
  

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet28.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Segment Information and Geographic Data (Tables)
3 Months Ended
Dec. 27, 2014
Summary Information by Operating Segment

The following table shows information by operating segment for the three months ended December 27, 2014 and December 28, 2013 (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
     December 28,
2013
 

Americas:

     

Net sales

   $ 30,566       $ 24,789   

Operating income

   $ 10,701       $ 8,069   
     

Europe:

     

Net sales

   $ 17,214       $ 14,335   

Operating income

   $ 5,882       $ 4,623   

Greater China:

     

Net sales

   $ 16,144       $ 9,496   

Operating income

   $ 6,366       $ 3,247   
     

Japan:

     

Net sales

   $ 5,448       $ 5,045   

Operating income

   $ 2,488       $ 2,330   

Rest of Asia Pacific:

     

Net sales

   $ 5,227       $ 3,929   

Operating income

   $ 1,849       $ 1,368   
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations

A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 27, 2014 and December 28, 2013 is as follows (in millions):

 

                                                 
     Three Months Ended  
     December 27,
2014
    December 28,
2013
 

Segment operating income

   $ 27,286      $ 19,637   

Research and development expense

     (1,895     (1,330

Other corporate expenses, net

     (1,145     (844
  

 

 

   

 

 

 

Total operating income

   $ 24,246      $ 17,463   
  

 

 

   

 

 

 
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet29.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)
In Millions, except Share data in Thousands, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Numerator:
Net income $ 18,024 $ 13,072
Denominator:
Weighted-average shares outstanding 5,843,082 6,272,504
Effect of dilutive securities 38,721 37,657
Weighted-average diluted shares 5,881,803 6,310,161
Basic earnings per share $ 3.08 $ 2.08
Diluted earnings per share $ 3.06 $ 2.07
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet30.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Dec. 28, 2013
Sep. 28, 2013
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost $ 178,788 $ 155,332
Unrealized Gains 271 418
Unrealized Losses (1,104) (511)
Fair Value 177,955 155,239
Cash and cash equivalents 19,478 13,844 14,077 14,259
Short-term marketable securities 12,985 11,233
Long-term marketable securities 145,492 130,162
Cash
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 13,757 10,232
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 13,757 10,232
Cash and cash equivalents 13,757 10,232
Short-term marketable securities 0 0
Long-term marketable securities 0 0
Level 1
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 5,890 [1] 4,077 [1]
Unrealized Gains 0 [1] 1 [1]
Unrealized Losses (159) [1] (132) [1]
Fair Value 5,731 [1] 3,946 [1]
Cash and cash equivalents 3,346 [1] 1,546 [1]
Short-term marketable securities 2,385 [1] 2,400 [1]
Long-term marketable securities 0 [1] 0 [1]
Level 1 | Money market funds
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 3,346 [1] 1,546 [1]
Unrealized Gains 0 [1] 0 [1]
Unrealized Losses 0 [1] 0 [1]
Fair Value 3,346 [1] 1,546 [1]
Cash and cash equivalents 3,346 [1] 1,546 [1]
Short-term marketable securities 0 [1] 0 [1]
Long-term marketable securities 0 [1] 0 [1]
Level 1 | Mutual funds
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 2,544 [1] 2,531 [1]
Unrealized Gains 0 [1] 1 [1]
Unrealized Losses (159) [1] (132) [1]
Fair Value 2,385 [1] 2,400 [1]
Cash and cash equivalents 0 [1] 0 [1]
Short-term marketable securities 2,385 [1] 2,400 [1]
Long-term marketable securities 0 [1] 0 [1]
Level 2
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 159,141 [2] 141,023 [2]
Unrealized Gains 271 [2] 417 [2]
Unrealized Losses (945) [2] (379) [2]
Fair Value 158,467 [2] 141,061 [2]
Cash and cash equivalents 2,375 [2] 2,066 [2]
Short-term marketable securities 10,600 [2] 8,833 [2]
Long-term marketable securities 145,492 [2] 130,162 [2]
Level 2 | U.S. Treasury securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 35,107 [2] 23,140 [2]
Unrealized Gains 16 [2] 15 [2]
Unrealized Losses (58) [2] (9) [2]
Fair Value 35,065 [2] 23,146 [2]
Cash and cash equivalents 545 [2] 12 [2]
Short-term marketable securities 692 [2] 607 [2]
Long-term marketable securities 33,828 [2] 22,527 [2]
Level 2 | U.S. agency securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 6,788 [2] 7,373 [2]
Unrealized Gains 2 [2] 3 [2]
Unrealized Losses (11) [2] (11) [2]
Fair Value 6,779 [2] 7,365 [2]
Cash and cash equivalents 582 [2] 652 [2]
Short-term marketable securities 291 [2] 157 [2]
Long-term marketable securities 5,906 [2] 6,556 [2]
Level 2 | Non-U.S. government securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 6,498 [2] 6,925 [2]
Unrealized Gains 58 [2] 69 [2]
Unrealized Losses (105) [2] (69) [2]
Fair Value 6,451 [2] 6,925 [2]
Cash and cash equivalents 0 [2] 0 [2]
Short-term marketable securities 177 [2] 204 [2]
Long-term marketable securities 6,274 [2] 6,721 [2]
Level 2 | Certificates of deposit and time deposits
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 2,778 [2] 3,832 [2]
Unrealized Gains 0 [2] 0 [2]
Unrealized Losses 0 [2] 0 [2]
Fair Value 2,778 [2] 3,832 [2]
Cash and cash equivalents 272 [2] 1,230 [2]
Short-term marketable securities 1,168 [2] 1,233 [2]
Long-term marketable securities 1,338 [2] 1,369 [2]
Level 2 | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 1,159 [2] 475 [2]
Unrealized Gains 0 [2] 0 [2]
Unrealized Losses 0 [2] 0 [2]
Fair Value 1,159 [2] 475 [2]
Cash and cash equivalents 879 [2] 166 [2]
Short-term marketable securities 280 [2] 309 [2]
Long-term marketable securities 0 [2] 0 [2]
Level 2 | Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 92,371 [2] 85,431 [2]
Unrealized Gains 159 [2] 296 [2]
Unrealized Losses (720) [2] (241) [2]
Fair Value 91,810 [2] 85,486 [2]
Cash and cash equivalents 97 [2] 6 [2]
Short-term marketable securities 7,932 [2] 6,298 [2]
Long-term marketable securities 83,781 [2] 79,182 [2]
Level 2 | Municipal securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 939 [2] 940 [2]
Unrealized Gains 4 [2] 8 [2]
Unrealized Losses (1) [2] 0 [2]
Fair Value 942 [2] 948 [2]
Cash and cash equivalents 0 [2] 0 [2]
Short-term marketable securities 0 [2] 0 [2]
Long-term marketable securities 942 [2] 948 [2]
Level 2 | Mortgage- and asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost 13,501 [2] 12,907 [2]
Unrealized Gains 32 [2] 26 [2]
Unrealized Losses (50) [2] (49) [2]
Fair Value 13,483 [2] 12,884 [2]
Cash and cash equivalents 0 [2] 0 [2]
Short-term marketable securities 60 [2] 25 [2]
Long-term marketable securities $ 13,423 [2] $ 12,859 [2]
[1] The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
[2] The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet31.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Financial Instruments - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended
Dec. 27, 2014
Sep. 27, 2014
Financial Instruments [Line Items]
Maturities of long-term marketable securities, minimum 1 year
Maturities of long-term marketable securities, maximum 5 years
Hedged foreign currency transactions, typical term 12 months
Hedged interest rate transactions, expected period to be recognized 12 years
Net cash collateral received, derivative instruments 4,200,000,000 2,100,000,000
Reduction to derivative assets by rights of set-off associated with derivative contracts 4,200,000,000 1,600,000,000
Reduction to derivative liabilities by rights of set-off associated with derivative contracts 4,200,000,000 1,600,000,000
Net derivative assets (liabilities) (184,000,000) (549,000,000)
Number of customers representing 10% or more of trade receivables 1 2
Number of vendors representing a significant portion of non-trade receivables 3 3
Trade Receivables | Credit Concentration Risk | Customer One
Financial Instruments [Line Items]
Concentration risk, percentage 13.00% 16.00%
Trade Receivables | Credit Concentration Risk | Customer Two
Financial Instruments [Line Items]
Concentration risk, percentage 13.00%
Trade Receivables | Credit Concentration Risk | Total Cellular Network Carriers
Financial Instruments [Line Items]
Concentration risk, percentage 63.00% 72.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor One
Financial Instruments [Line Items]
Concentration risk, percentage 57.00% 51.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor Two
Financial Instruments [Line Items]
Concentration risk, percentage 14.00% 16.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor Three
Financial Instruments [Line Items]
Concentration risk, percentage 12.00% 14.00%
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet32.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Derivative Instruments at Gross Fair Value (Detail) (Level 2, USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets $ 4,062 [1] $ 1,554 [1]
Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities 170 [2] 81 [2]
Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets 201 [1] 81 [1]
Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities 87 [2]
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets 3,561 [1] 1,332 [1]
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities 51 [2] 41 [2]
Derivatives Designated as Hedging Instruments | Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets 201 [1] 81 [1]
Derivatives Designated as Hedging Instruments | Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities 87 [2]
Not Designated as Hedging Instrument | Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets 501 [1] 222 [1]
Not Designated as Hedging Instrument | Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities 119 [2] 40 [2]
Not Designated as Hedging Instrument | Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets 0 [1] 0 [1]
Not Designated as Hedging Instrument | Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities $ 0 [2]
[1] The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
[2] The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet33.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Pre-Tax Effect of Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) Recognized in OCI - Effective Portion $ 2,497 $ 285
Gains/(Losses) Reclassified from AOCI into Net Income - Effective Portion 663 (78)
Cash flow hedges | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) Recognized in OCI - Effective Portion 2,585 264
Gains/(Losses) Reclassified from AOCI into Net Income - Effective Portion 762 (74)
Cash flow hedges | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) Recognized in OCI - Effective Portion (88) 21
Gains/(Losses) Reclassified from AOCI into Net Income - Effective Portion (99) (4)
Net investment hedges | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) Recognized in OCI - Effective Portion 118 24
Gains/(Losses) Reclassified from AOCI into Net Income - Effective Portion 0 0
Fair Value Hedges | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) on Derivative Instruments 117 0
Gains/(Losses) Related to Hedged Items $ (117) $ 0
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet34.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Derivatives Designated as Hedging Instruments | Foreign exchange contracts
Derivative [Line Items]
Notional Amount $ 55,761 $ 42,945
Credit Risk 3,561 1,333
Derivatives Designated as Hedging Instruments | Interest rate contracts
Derivative [Line Items]
Notional Amount 15,513 12,000
Credit Risk 201 89
Not Designated as Hedging Instrument | Foreign exchange contracts
Derivative [Line Items]
Notional Amount 39,872 38,510
Credit Risk $ 501 $ 222
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet35.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Inventory (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Inventory [Line Items]
Components $ 228 $ 471
Finished goods 2,055 1,640
Total inventories $ 2,283 $ 2,111
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet36.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Property, Plant and Equipment, Net (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment $ 40,747 $ 39,015
Accumulated depreciation and amortization (20,355) (18,391)
Total property, plant and equipment, net 20,392 20,624
Land and Buildings
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment 5,152 4,863
Machinery, Equipment and Internal-Use Software
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment 31,010 29,639
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment $ 4,585 $ 4,513
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet37.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Accrued Expenses (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Dec. 28, 2013
Sep. 28, 2013
Schedule of Accrued Liabilities [Line Items]
Accrued warranty and related costs $ 5,195 $ 4,159 $ 3,980 $ 2,967
Accrued marketing and selling expenses 1,960 2,321
Accrued taxes 1,642 1,209
Accrued compensation and employee benefits 1,316 1,209
Deferred margin on component sales 1,133 1,057
Other current liabilities 11,478 8,498
Total accrued expenses $ 22,724 $ 18,453
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet38.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Other Non-Current Liabilities (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Schedule of Other Liabilities [Line Items]
Deferred tax liabilities $ 23,371 $ 20,259
Other non-current liabilities 5,600 4,567
Total other non-current liabilities $ 28,971 $ 24,826
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet39.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Other Income/(Expense), Net (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Other Income Expense [Line Items]
Interest and dividend income $ 654 $ 427
Interest expense (131) (84)
Other expense, net (353) (97)
Total other income/(expense), net $ 170 $ 246
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet40.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Goodwill and Other Intangible Assets - Additional Information (Detail)
3 Months Ended
Dec. 27, 2014
Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Amortized acquired intangible assets with definite lives useful period (in years) 3 years
Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Amortized acquired intangible assets with definite lives useful period (in years) 7 years
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet41.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Components of Gross and Net Intangible Asset Balances (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Acquired Intangible Assets Including Goodwill [Line Items]
Definite-lived and amortizable acquired intangible assets, Gross Carrying Amount $ 7,641 $ 7,127
Definite-lived and amortizable acquired intangible assets, Accumulated Amortization (3,371) (3,085)
Definite-lived and amortizable acquired intangible assets, Net Carrying Amount 4,270 4,042
Indefinite-lived and non-amortizable acquired intangible assets 100 100
Total acquired intangible assets, Net Carrying Amount $ 4,370 $ 4,142
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet42.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Income Taxes - Additional Information (Detail) (USD $)
Dec. 27, 2014
Sep. 27, 2014
Income Tax Contingency [Line Items]
Gross unrecognized tax benefits $ 4,400,000,000 $ 4,000,000,000
Gross unrecognized tax benefits that would affect effective tax rate, if recognized 1,600,000,000 1,400,000,000
Unrecognized tax benefits, gross interest and penalties accrued $ 821,000,000 $ 630,000,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet43.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Debt - Additional Information (Detail)
3 Months Ended 3 Months Ended
Dec. 27, 2014
USD ($)
Dec. 28, 2013
USD ($)
Sep. 27, 2014
USD ($)
Dec. 27, 2014
2015 Euro-Denominated Debt Issuance
EUR (€)
Dec. 27, 2014
Currency Swap
USD ($)
Dec. 27, 2014
Maximum
Dec. 27, 2014
Level 2
USD ($)
Sep. 27, 2014
Level 2
USD ($)
Debt Instrument [Line Items]
Commercial paper $ 3,899,000,000 $ 6,308,000,000
Commercial paper, weighted-average interest rate 0.11% 0.12%
Commercial paper, maturity period 9 months
Debt instrument aggregate principal amount 32,418,000,000 29,000,000,000 2,800,000,000
Notional Amount 3,500,000,000
Interest expense 128,000,000 84,000,000
Debt instrument fair value $ 32,400,000,000 $ 28,500,000,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet44.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Maturities less than 90 days:
Proceeds from (repayments of) commercial paper, net $ 62
Maturities greater than 90 days:
Proceeds from commercial paper 197
Repayments of commercial paper (2,668)
Maturities greater than 90 days, net (2,471)
Total repayments of commercial paper, net $ (2,409) $ 0
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet45.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Long-Term Debt (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Debt Instrument [Line Items]
Total borrowings $ 32,418 $ 29,000
Unamortized discount (69) (52)
Hedge accounting fair value adjustments 155 39
Total long-term debt 32,504 28,987
Floating-rate notes due 2016
Debt Instrument [Line Items]
Debt instrument, senior notes 1,000 [1] 1,000 [1]
Debt instrument effective interest rate 0.51% [1] 0.51% [1]
Floating-rate notes due 2017
Debt Instrument [Line Items]
Debt instrument, senior notes 1,000 [2] 1,000 [2]
Debt instrument effective interest rate 0.30% [2] 0.31% [2]
Floating-rate notes due 2018
Debt Instrument [Line Items]
Debt instrument, senior notes 2,000 [1] 2,000 [1]
Debt instrument effective interest rate 1.10% [1] 1.10% [1]
Floating-rate notes due 2019
Debt Instrument [Line Items]
Debt instrument, senior notes 1,000 [2] 1,000 [2]
Debt instrument effective interest rate 0.53% [2] 0.54% [2]
Fixed-rate 0.45% notes due 2016
Debt Instrument [Line Items]
Debt instrument, senior notes 1,500 [1] 1,500 [1]
Debt instrument effective interest rate 0.51% [1] 0.51% [1]
Fixed-rate 1.05% notes due 2017
Debt Instrument [Line Items]
Debt instrument, senior notes 1,500 [2] 1,500 [2]
Debt instrument effective interest rate 0.30% [2] 0.30% [2]
Fixed-rate 1.00% notes due 2018
Debt Instrument [Line Items]
Debt instrument, senior notes 4,000 [1] 4,000 [1]
Debt instrument effective interest rate 1.08% [1] 1.08% [1]
Fixed-rate 2.10% notes due 2019
Debt Instrument [Line Items]
Debt instrument, senior notes 2,000 [2] 2,000 [2]
Debt instrument effective interest rate 0.53% [2] 0.53% [2]
Fixed-rate 2.85% notes due 2021
Debt Instrument [Line Items]
Debt instrument, senior notes 3,000 [2] 3,000 [2]
Debt instrument effective interest rate 0.78% [2] 0.79% [2]
Fixed-rate 1.00% Euro-denominated notes due 2022
Debt Instrument [Line Items]
Debt instrument, senior notes 1,709 [3] 0 [3]
Debt instrument effective interest rate 2.94% [3] 0.00% [3]
Fixed-rate 2.40% notes due 2023
Debt Instrument [Line Items]
Debt instrument, senior notes 5,500 [1] 5,500 [1]
Debt instrument effective interest rate 2.44% [1] 2.44% [1]
Fixed-rate 3.45% notes due 2024
Debt Instrument [Line Items]
Debt instrument, senior notes 2,500 [2] 2,500 [2]
Debt instrument effective interest rate 0.89% [2] 0.90% [2]
Fixed-rate 1.63% Euro-denominated notes due 2026
Debt Instrument [Line Items]
Debt instrument, senior notes 1,709 [3] 0 [3]
Debt instrument effective interest rate 3.45% [3] 0.00% [3]
Fixed-rate 3.85% notes due 2043
Debt Instrument [Line Items]
Debt instrument, senior notes 3,000 [1] 3,000 [1]
Debt instrument effective interest rate 3.91% [1] 3.91% [1]
Fixed-rate 4.45% notes due 2044
Debt Instrument [Line Items]
Debt instrument, senior notes $ 1,000 [2] $ 1,000 [2]
Debt instrument effective interest rate 4.48% [2] 4.48% [2]
[1] Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013.
[2] Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014.
[3] Tranche relates to Euro-denominated debt issuance of €2.8 billion in the first quarter of 2015.
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet46.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Long-Term Debt (Parenthetical) (Detail)
In Millions, unless otherwise specified
Dec. 27, 2014
USD ($)
Sep. 27, 2014
USD ($)
Dec. 27, 2014
Floating-rate notes due 2016
Sep. 27, 2014
Floating-rate notes due 2016
Dec. 27, 2014
Floating-rate notes due 2017
Sep. 27, 2014
Floating-rate notes due 2017
Dec. 27, 2014
Floating-rate notes due 2018
Sep. 27, 2014
Floating-rate notes due 2018
Dec. 27, 2014
Floating-rate notes due 2019
Sep. 27, 2014
Floating-rate notes due 2019
Dec. 27, 2014
Fixed-rate 0.45% notes due 2016
Sep. 27, 2014
Fixed-rate 0.45% notes due 2016
Dec. 27, 2014
Fixed-rate 1.05% notes due 2017
Sep. 27, 2014
Fixed-rate 1.05% notes due 2017
Dec. 27, 2014
Fixed-rate 1.00% notes due 2018
Sep. 27, 2014
Fixed-rate 1.00% notes due 2018
Dec. 27, 2014
Fixed-rate 2.10% notes due 2019
Sep. 27, 2014
Fixed-rate 2.10% notes due 2019
Dec. 27, 2014
Fixed-rate 2.85% notes due 2021
Sep. 27, 2014
Fixed-rate 2.85% notes due 2021
Dec. 27, 2014
Fixed-rate 1.00% Euro-denominated notes due 2022
Sep. 27, 2014
Fixed-rate 1.00% Euro-denominated notes due 2022
Dec. 27, 2014
Fixed-rate 2.40% notes due 2023
Sep. 27, 2014
Fixed-rate 2.40% notes due 2023
Dec. 27, 2014
Fixed-rate 3.45% notes due 2024
Sep. 27, 2014
Fixed-rate 3.45% notes due 2024
Dec. 27, 2014
Fixed-rate 1.63% Euro-denominated notes due 2026
Sep. 27, 2014
Fixed-rate 1.63% Euro-denominated notes due 2026
Dec. 27, 2014
Fixed-rate 3.85% notes due 2043
Sep. 27, 2014
Fixed-rate 3.85% notes due 2043
Dec. 27, 2014
Fixed-rate 4.45% notes due 2044
Sep. 27, 2014
Fixed-rate 4.45% notes due 2044
Jun. 29, 2013
2013 Debt Issuance
USD ($)
Jun. 28, 2014
2014 Debt Issuance
USD ($)
Dec. 27, 2014
2015 Euro-Denominated Debt Issuance
EUR (€)
Debt Instrument [Line Items]
Debt instrument maturity year 2016 2016 2017 2017 2018 2018 2019 2019 2016 2016 2017 2017 2018 2018 2019 2019 2021 2021 2022 2022 2023 2023 2024 2024 2026 2026 2043 2043 2044 2044
Debt instrument interest rate 0.45% 0.45% 1.05% 1.05% 1.00% 1.00% 2.10% 2.10% 2.85% 2.85% 1.00% 1.00% 2.40% 2.40% 3.45% 3.45% 1.63% 1.63% 3.85% 3.85% 4.45% 4.45%
Debt instrument aggregate principal amount $ 32,418 $ 29,000 $ 17,000 $ 12,000 € 2,800
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet47.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Debt Instrument Future Principal Payments (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Long Term Debt Maturities Repayments Of Principal [Line Items]
2015 $ 0
2016 2,500
2017 2,500
2018 6,000
2019 3,000
Thereafter 18,418
Total future principal payments $ 32,418 $ 29,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet48.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Dividends Declared and Paid (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 27, 2014
Sep. 27, 2014
Jun. 28, 2014
Mar. 29, 2014
Dec. 28, 2013
Sep. 27, 2014
Dividends [Line Items]
Dividend Per Share $ 0.47 $ 0.47 $ 0.47 $ 0.44 $ 0.44 $ 1.82
Amount $ 2,750 $ 2,807 $ 2,830 $ 2,655 $ 2,739 $ 11,031
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet49.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Shareholders' Equity - Additional Information (Detail) (USD $)
In Billions, unless otherwise specified
Dec. 27, 2014
Sep. 27, 2014
Stockholders Equity Note Disclosure [Line Items]
Maximum amount authorized for repurchase of common stock $ 90
Share repurchase program, utilized amount $ 72.9
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet50.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Accelerated Share Repurchase Activity and Related Information (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 5 Months Ended 12 Months Ended
Dec. 27, 2014
Dec. 27, 2014
Dec. 27, 2014
Mar. 31, 2014
August 2014 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date    [1]
Number of Shares 8,300 68,273 [1]
Average Repurchase Price Per Share    [1]
ASR Amount $ 9,000
January 2014 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date December 2014
Number of Shares 134,247
Average Repurchase Price Per Share $ 89.39
ASR Amount 12,000
April 2013 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date March 2014
Number of Shares 172,548
Average Repurchase Price Per Share $ 69.55
ASR Amount $ 12,000
[1] Includes 8.3 million net shares delivered and retired under the August 2014 ASR in the first quarter of 2015. "Number of Shares" represents those shares delivered in advance of settlement and does not represent the final number of shares to be delivered under the ASRs. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company's common stock during that period. The August 2014 ASR purchase period will end in or before February 2015.
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet51.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Accelerated Share Repurchase Activity and Related Information (Parenthetical) (Detail) (August 2014 ASR)
In Thousands, unless otherwise specified
3 Months Ended 5 Months Ended
Dec. 27, 2014
Dec. 27, 2014
August 2014 ASR
Accelerated Share Repurchases [Line Items]
Number of shares repurchased and retired 8,300 68,273 [1]
[1] Includes 8.3 million net shares delivered and retired under the August 2014 ASR in the first quarter of 2015. "Number of Shares" represents those shares delivered in advance of settlement and does not represent the final number of shares to be delivered under the ASRs. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company's common stock during that period. The August 2014 ASR purchase period will end in or before February 2015.
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet52.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Repurchases of Common Shares in Open Market (Detail) (Open Market Repurchases, USD $)
In Millions, except Share data in Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 27, 2014
Sep. 27, 2014
Jun. 28, 2014
Mar. 29, 2014
Dec. 28, 2013
Sep. 27, 2014
Open Market Repurchases
Stock Repurchase Program [Line Items]
Number of Shares 45,704 81,255 58,661 79,749 66,847 286,512
Average Repurchase Price Per Share $ 109.4 $ 98.46 $ 85.23 $ 75.24 $ 74.79
Amount $ 5,000 $ 8,000 $ 5,000 $ 6,000 $ 5,000 $ 24,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet53.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Gross Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrecognized gains/losses on derivative instruments reclassified from AOCI $ (663) $ 88
Unrealized gains/losses on marketable securities reclassified from AOCI (22) (17)
Total amounts reclassified from AOCI (685) 71
Foreign exchange contracts | Revenue
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrecognized gains/losses on derivative instruments reclassified from AOCI (449) 184
Foreign exchange contracts | Cost of sales
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrecognized gains/losses on derivative instruments reclassified from AOCI (313) (110)
Foreign exchange contracts | Other income/expense, net
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrecognized gains/losses on derivative instruments reclassified from AOCI 0 10
Interest rate contracts | Other income/expense, net
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrecognized gains/losses on derivative instruments reclassified from AOCI $ 99 $ 4
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet54.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Change in Accumulated Other Comprehensive Income by Component (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance $ 1,082
Other comprehensive income/(loss) before reclassifications 1,569
Amounts reclassified from AOCI (685) 71
Tax effect (3)
Total other comprehensive income/(loss) 881 165
Ending balance 1,963
Cumulative Foreign Currency Translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance (242)
Other comprehensive income/(loss) before reclassifications (114)
Amounts reclassified from AOCI 0
Tax effect 48
Total other comprehensive income/(loss) (66)
Ending balance (308)
Unrecognized Gains/Losses on Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance 1,364
Other comprehensive income/(loss) before reclassifications 2,390
Amounts reclassified from AOCI (663)
Tax effect (310)
Total other comprehensive income/(loss) 1,417
Ending balance 2,781
Unrealized Gains/Losses on Marketable Securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance (40)
Other comprehensive income/(loss) before reclassifications (707)
Amounts reclassified from AOCI (22)
Tax effect 259
Total other comprehensive income/(loss) (470)
Ending balance $ (510)
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet55.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Benefit Plans - Additional Information (Detail) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance under stock plans (in shares) 436.9
RSUs granted vesting period 4 years
Fair value of vested RSUs as of vesting date $ 1,700,000,000 $ 1,100,000,000
Stock options outstanding 3.5
Stock options, Weighted average exercise price per share $ 19.61
Stock options, Weighted average remaining contractual term 2 years 2 months 12 days
Stock options, Aggregate intrinsic value 330,000,000
Total intrinsic value of options at the time of exercise 248,000,000 559,000,000
Income tax benefit related to share-based compensation expense 351,000,000 265,000,000
Total unrecognized compensation cost on stock options and RSUs $ 8,800,000,000
Total unrecognized compensation cost on stock options and RSUs, weighted-average recognition period (in years) 3 years 1 month 6 days
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet56.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Restricted Stock Units Activity and Related Information (Detail) (Restricted Stock Units, USD $)
In Millions, except Share data in Thousands, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Restricted Stock Units
Number of Restricted Stock Units
Beginning Balance 103,822
Restricted stock units granted 36,294
Restricted stock units vested (16,759)
Restricted stock units cancelled (1,815)
Ending Balance 121,542
Weighted-Average Grant Date Fair Value Per Share
Beginning Balance $ 70.98
Restricted stock units granted $ 101.41
Restricted stock units vested $ 64.3
Restricted stock units cancelled $ 71.49
Ending Balance $ 80.98
Aggregate Intrinsic Value
Aggregate intrinsic value of Restricted stock units $ 13,855
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet57.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary of Share-Based Compensation Expense (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense $ 888 $ 681
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense 140 109
Research and Development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense 374 289
Selling, General and Administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense $ 374 $ 283
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet58.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Changes in Accrued Warranties and Related Costs (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning accrued warranty and related costs $ 4,159 $ 2,967
Cost of warranty claims (1,044) (1,064)
Accruals for product warranty 2,080 2,077
Ending accrued warranty and related costs $ 5,195 $ 3,980
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet59.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Commitments and Contingencies - Additional Information (Detail) (USD $)
3 Months Ended
Dec. 27, 2014
Store
Sep. 27, 2014
Mar. 06, 2014
Aug. 24, 2012
Commitments and Contingencies Disclosure [Line Items]
Purchase commitments maximum period 150 days
Number of retail stores 447
Total future minimum lease payments under noncancelable operating leases $ 4,800,000,000
Outstanding off-balance sheet third party manufacturing commitments and component purchase commitments 21,600,000,000
Additional off-balance sheet obligations 3,900,000,000
Indemnification Agreement
Commitments and Contingencies Disclosure [Line Items]
Liability for infringement costs 0 0
Major Facility Lease | Maximum
Commitments and Contingencies Disclosure [Line Items]
Term of leases 10 years
Retail Space Lease
Commitments and Contingencies Disclosure [Line Items]
Total future minimum lease payments under noncancelable operating leases 3,500,000,000
Retail Space Lease | Maximum
Commitments and Contingencies Disclosure [Line Items]
Term of leases 20 years
Retail Space Lease | Minimum
Commitments and Contingencies Disclosure [Line Items]
Term of leases 5 years
Retail Space Lease | Majority
Commitments and Contingencies Disclosure [Line Items]
Term of leases 10 years
Samsung Electronics Co Ltd
Commitments and Contingencies Disclosure [Line Items]
Result of legal proceedings 1,050,000,000
Award from legal proceeding $ 930,000,000
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet60.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Summary Information by Operating Segment (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Segment Reporting Information [Line Items]
Net sales $ 74,599 $ 57,594
Operating income 24,246 17,463
Americas
Segment Reporting Information [Line Items]
Net sales 30,566 24,789
Operating income 10,701 8,069
Europe
Segment Reporting Information [Line Items]
Net sales 17,214 14,335
Operating income 5,882 4,623
Greater China
Segment Reporting Information [Line Items]
Net sales 16,144 9,496
Operating income 6,366 3,247
Japan
Segment Reporting Information [Line Items]
Net sales 5,448 5,045
Operating income 2,488 2,330
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales 5,227 3,929
Operating income $ 1,849 $ 1,368
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/Sheet61.html Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii"
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 27, 2014
Dec. 28, 2013
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income $ 24,246 $ 17,463
Research and development expense (1,895) (1,330)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income 27,286 19,637
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense (1,895) (1,330)
Corporate Non-Segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net $ (1,145) $ (844)
------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8 Content-Location: file:///C:/62356c1a_6970_45ff_b8e1_aa8499d8dda8/Worksheets/filelist.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" ------=_NextPart_62356c1a_6970_45ff_b8e1_aa8499d8dda8--